시장보고서

상품코드

1559437

세계의 인간 면역글로불린 시장(2024-2028년)

Global Human Immunoglobulin Market 2024-2028

발행일: 2024년 08월 | 리서치사:

TechNavio | 페이지 정보: 영문 215 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

인간 면역글로불린 시장은 2023-2028년간 96억 9,600만 달러 확대되고, 예측 기간 동안 10.11%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

인간 면역글로불린(Human Immunoglobulin) 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 전해드립니다.

현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 혈장 기증 증가, 면역 결핍 질환의 유병률 증가, 노령 인구 증가가 시장을 주도하고 있습니다.

시장 범위
기준년도	2024년
종료년도	2028년
예측 기간	2024-2028년
성장 모멘텀	가속
2024년 전년 대비	8.65%
CAGR	10.11%
증분 금액	96억 9,600만 달러

이 보고서는 향후 몇 년동안 인간 면역글로불린 시장 성장을 주도할 주요 요인 중 하나로 인간 면역글로불린에 대한 연구 개발 증가를 꼽았습니다. 또한, 인간 면역글로불린에 대한 규제 승인 증가와 인간 면역글로불린 생산에 대한 제조 기술의 발전은 시장의 큰 수요를 창출할 것으로 예상됩니다.

시장 세분화
비교 : 용도별
자가면역 질환 : 시장 규모와 예측(2023-2028년)
혈액 질환 : 시장 규모와 예측(2023-2028년)
염증성 질환 : 시장 규모와 예측(2023-2028년)
감염증 : 시장 규모와 예측(2023-2028년)
기타 : 시장 규모와 예측(2023-2028년)
시장 기회 : 용도별

제9장 시장 세분화 : 최종사용자별

시장 세분화
비교 : 최종사용자별
병원 : 시장 규모와 예측(2023-2028년)
클리닉 : 시장 규모와 예측(2023-2028년)
외래수술센터(ASC) : 시장 규모와 예측(2023-2028년)
시장 기회 : 최종사용자별

제10장 고객 상황

고객 상황 개요

제11장 지역별 상황

지역별 세분화
지역별 비교
북미 : 시장 규모와 예측(2023-2028년)
유럽 : 시장 규모와 예측(2023-2028년)
아시아 : 시장 규모와 예측(2023-2028년)
세계 기타 지역 : 시장 규모와 예측(2023-2028년)
미국 : 시장 규모와 예측(2023-2028년)
중국 : 시장 규모와 예측(2023-2028년)
프랑스 : 시장 규모와 예측(2023-2028년)
영국 : 시장 규모와 예측(2023-2028년)
독일 : 시장 규모와 예측(2023-2028년)
스페인 : 시장 규모와 예측(2023-2028년)
일본 : 시장 규모와 예측(2023-2028년)
한국 : 시장 규모와 예측(2023-2028년)
브라질 : 시장 규모와 예측(2023-2028년)
인도 : 시장 규모와 예측(2023-2028년)
시장 기회 : 지역 상황별

제12장 성장 촉진요인, 과제, 기회, 억제요인

시장 성장 촉진요인
시장이 해결해야 할 과제
성장 촉진요인과 과제의 영향
시장 기회, 성장 억제요인

제13장 경쟁 구도

개요
경쟁 구도
혼란 상황
업계 리스크

제14장 경쟁 분석

기업 개요
기업 순위 지수
기업의 시장 포지셔닝
ADMA Biologics Inc.
Baxter International Inc.
Bio Products Laboratory Ltd.
CSL Ltd.
Emergent BioSolutions Inc.
Grifols SA
Hualan Biological Vaccine Inc.
Kamada Ltd.
Kedrion Spa
LFB SA
Octapharma AG
Pfizer Inc.
Prothya Biosolutions Netherlands BV
Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd
Takeda Pharmaceutical Co. Ltd.

제15장 부록

LSH 24.10.23

The human immunoglobulin market is forecasted to grow by USD 9696 mn during 2023-2028, accelerating at a CAGR of 10.11% during the forecast period. The report on the human immunoglobulin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in plasma donation, rising prevalence of immunodeficiency disorders, and growing geriatric population.

Technavio's human immunoglobulin market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	8.65%
CAGR	10.11%
Incremental Value	$9696 mn

By Application

Autoimmune disorders
Hematology diseases
Inflammatory diseases
Infectious diseases
Others

By End-user

Hospitals
Clinics
Ambulatory surgical center (ASC)

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the rising research and development in human immunoglobulin as one of the prime reasons driving the human immunoglobulin market growth during the next few years. Also, growing regulatory approvals on human immunoglobulin and advancements in manufacturing technologies in production of human immunoglobulin will lead to sizable demand in the market.

The report on the human immunoglobulin market covers the following areas:

Human immunoglobulin market sizing
Human immunoglobulin market forecast
Human immunoglobulin market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human immunoglobulin market vendors that include ADMA Biologics Inc., argenx SE, Baxter International Inc., Bio Products Laboratory Ltd., CSL Ltd., Emergent BioSolutions Inc., Grifols SA, Hualan Biological Vaccine Inc., Kamada Ltd., Kedrion Spa, LFB SA, Octapharma AG, Pfizer Inc., Prothya Biosolutions Netherlands BV, Sanquin, Shanghai RAAS Blood Products Co. Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd, and Takeda Pharmaceutical Co. Ltd.. Also, the human immunoglobulin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value Chain Analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2023
4.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

5.1 Global Human Immunoglobulin Market 2018 - 2022
- Historic Market Size - Data Table on Global Human Immunoglobulin Market 2018 - 2022 ($ million)
5.2 Application segment analysis 2018 - 2022
- Historic Market Size - Application Segment 2018 - 2022 ($ million)
5.3 End-user segment analysis 2018 - 2022
- Historic Market Size - End-user Segment 2018 - 2022 ($ million)
5.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
5.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on the Global Human Immunoglobulin Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
7.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

8 Market Segmentation by Application

8.1 Market segments
- Chart on Application - Market share 2023-2028 (%)
- Data Table on Application - Market share 2023-2028 (%)
8.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
8.3 Autoimmune disorders - Market size and forecast 2023-2028
- Chart on Autoimmune disorders - Market size and forecast 2023-2028 ($ million)
- Data Table on Autoimmune disorders - Market size and forecast 2023-2028 ($ million)
- Chart on Autoimmune disorders - Year-over-year growth 2023-2028 (%)
- Data Table on Autoimmune disorders - Year-over-year growth 2023-2028 (%)
8.4 Hematology diseases - Market size and forecast 2023-2028
- Chart on Hematology diseases - Market size and forecast 2023-2028 ($ million)
- Data Table on Hematology diseases - Market size and forecast 2023-2028 ($ million)
- Chart on Hematology diseases - Year-over-year growth 2023-2028 (%)
- Data Table on Hematology diseases - Year-over-year growth 2023-2028 (%)
8.5 Inflammatory diseases - Market size and forecast 2023-2028
- Chart on Inflammatory diseases - Market size and forecast 2023-2028 ($ million)
- Data Table on Inflammatory diseases - Market size and forecast 2023-2028 ($ million)
- Chart on Inflammatory diseases - Year-over-year growth 2023-2028 (%)
- Data Table on Inflammatory diseases - Year-over-year growth 2023-2028 (%)
8.6 Infectious diseases - Market size and forecast 2023-2028
- Chart on Infectious diseases - Market size and forecast 2023-2028 ($ million)
- Data Table on Infectious diseases - Market size and forecast 2023-2028 ($ million)
- Chart on Infectious diseases - Year-over-year growth 2023-2028 (%)
- Data Table on Infectious diseases - Year-over-year growth 2023-2028 (%)
8.7 Others - Market size and forecast 2023-2028
- Chart on Others - Market size and forecast 2023-2028 ($ million)
- Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Chart on Others - Year-over-year growth 2023-2028 (%)
- Data Table on Others - Year-over-year growth 2023-2028 (%)
8.8 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

9 Market Segmentation by End-user

9.1 Market segments
- Chart on End-user - Market share 2023-2028 (%)
- Data Table on End-user - Market share 2023-2028 (%)
9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
9.3 Hospitals - Market size and forecast 2023-2028
- Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
- Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
- Chart on Hospitals - Year-over-year growth 2023-2028 (%)
- Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
9.4 Clinics - Market size and forecast 2023-2028
- Chart on Clinics - Market size and forecast 2023-2028 ($ million)
- Data Table on Clinics - Market size and forecast 2023-2028 ($ million)
- Chart on Clinics - Year-over-year growth 2023-2028 (%)
- Data Table on Clinics - Year-over-year growth 2023-2028 (%)
9.5 Ambulatory surgical center (ASC) - Market size and forecast 2023-2028
- Chart on Ambulatory surgical center (ASC) - Market size and forecast 2023-2028 ($ million)
- Data Table on Ambulatory surgical center (ASC) - Market size and forecast 2023-2028 ($ million)
- Chart on Ambulatory surgical center (ASC) - Year-over-year growth 2023-2028 (%)
- Data Table on Ambulatory surgical center (ASC) - Year-over-year growth 2023-2028 (%)
9.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

10 Customer Landscape

10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

11.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
11.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
11.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
11.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
11.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
11.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
11.8 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
11.9 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
11.10 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
11.11 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
11.12 Spain - Market size and forecast 2023-2028
- Chart on Spain - Market size and forecast 2023-2028 ($ million)
- Data Table on Spain - Market size and forecast 2023-2028 ($ million)
- Chart on Spain - Year-over-year growth 2023-2028 (%)
- Data Table on Spain - Year-over-year growth 2023-2028 (%)
11.13 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
11.14 South Korea - Market size and forecast 2023-2028
- Chart on South Korea - Market size and forecast 2023-2028 ($ million)
- Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
- Chart on South Korea - Year-over-year growth 2023-2028 (%)
- Data Table on South Korea - Year-over-year growth 2023-2028 (%)
11.15 Brazil - Market size and forecast 2023-2028
- Chart on Brazil - Market size and forecast 2023-2028 ($ million)
- Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
- Chart on Brazil - Year-over-year growth 2023-2028 (%)
- Data Table on Brazil - Year-over-year growth 2023-2028 (%)
11.16 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)
11.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
12.4 Market opportunities/restraints

13 Competitive Landscape

13.1 Overview
13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
- Overview on factors of disruption
13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered
14.2 Company ranking index
- Company ranking index
14.3 Market positioning of companies
- Matrix on companies position and classification
14.4 ADMA Biologics Inc.
- ADMA Biologics Inc. - Overview
- ADMA Biologics Inc. - Business segments
- ADMA Biologics Inc. - Key news
- ADMA Biologics Inc. - Key offerings
- ADMA Biologics Inc. - Segment focus
- SWOT
14.5 Baxter International Inc.
- Baxter International Inc. - Overview
- Baxter International Inc. - Business segments
- Baxter International Inc. - Key news
- Baxter International Inc. - Key offerings
- Baxter International Inc. - Segment focus
- SWOT
14.6 Bio Products Laboratory Ltd.
- Bio Products Laboratory Ltd. - Overview
- Bio Products Laboratory Ltd. - Product / Service
- Bio Products Laboratory Ltd. - Key offerings
- SWOT
14.7 CSL Ltd.
- CSL Ltd. - Overview
- CSL Ltd. - Business segments
- CSL Ltd. - Key news
- CSL Ltd. - Key offerings
- CSL Ltd. - Segment focus
- SWOT
14.8 Emergent BioSolutions Inc.
- Emergent BioSolutions Inc. - Overview
- Emergent BioSolutions Inc. - Product / Service
- Emergent BioSolutions Inc. - Key offerings
- SWOT
14.9 Grifols SA
- Grifols SA - Overview
- Grifols SA - Business segments
- Grifols SA - Key news
- Grifols SA - Key offerings
- Grifols SA - Segment focus
- SWOT
14.10 Hualan Biological Vaccine Inc.
- Hualan Biological Vaccine Inc. - Overview
- Hualan Biological Vaccine Inc. - Product / Service
- Hualan Biological Vaccine Inc. - Key offerings
- SWOT
14.11 Kamada Ltd.
- Kamada Ltd. - Overview
- Kamada Ltd. - Business segments
- Kamada Ltd. - Key offerings
- Kamada Ltd. - Segment focus
- SWOT
14.12 Kedrion Spa
- Kedrion Spa - Overview
- Kedrion Spa - Product / Service
- Kedrion Spa - Key offerings
- SWOT
14.13 LFB SA
- LFB SA - Overview
- LFB SA - Product / Service
- LFB SA - Key offerings
- SWOT
14.14 Octapharma AG
- Octapharma AG - Overview
- Octapharma AG - Product / Service
- Octapharma AG - Key offerings
- SWOT
14.15 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
14.16 Prothya Biosolutions Netherlands BV
- Prothya Biosolutions Netherlands BV - Overview
- Prothya Biosolutions Netherlands BV - Product / Service
- Prothya Biosolutions Netherlands BV - Key offerings
- SWOT
14.17 Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd
- Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd - Overview
- Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd - Product / Service
- Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd - Key offerings
- SWOT
14.18 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- SWOT

15 Appendix

15.1 Scope of the report
15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
15.3 Currency conversion rates for US$
- Currency conversion rates for US$
15.4 Research methodology
- Research methodology
15.5 Data procurement
- Information sources
15.6 Data validation
- Data validation
15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
15.8 Data synthesis
- Data synthesis
15.9 360 degree market analysis
- 360 degree market analysis
15.10 List of abbreviations
- List of abbreviations